MCKESSON CORP forecast fiscal 2027 adjusted profit with a $44.20 midpoint, exceeding LSEG estimates of $44.10. The United States distributor earned $11.69 per share in the fourth quarter of fiscal 2026, beating expectations of $11.59. High-margin specialty drug demand is offsetting slower distribution trends seen at industry peers.
McKesson Forecasts 2027 Profit Above Analyst Estimates
McKesson expects fiscal 2027 earnings slightly above analyst targets as demand for specialty drugs remains strong. The company reported a quarterly profit beat.
Xurve View
Insights:
Xurve View







